Overview

Triglyceride Lowering Study

Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
Lovaza is a special fish oil concentrate, that prescribed at 4 g a day to reduce certain fat (triglycerides) levels in blood.Our goal is to study how Lovaza at doses of 4, 8, and 12 grams per day will reduce fats in the blood of the patients with very high level of triglycerides. Our hypothesis is that patients with very high triglycerides will respond more with higher doses of Lovaza (8 g per day and then 12 g per day).
Phase:
Phase 4
Details
Lead Sponsor:
Jewish Hospital, Cincinnati, Ohio
Collaborator:
GlaxoSmithKline